Professor Michael Good AO is an international leader in vaccine research and development. For over 25 years he has studied immunity to the malaria parasite and to Streptococcus pyogenes with the goal of identifying novel vaccine strategies. These organisms are responsible for the loss of over 1.5 million lives each year. He is currently undertaking Phase I vaccine trials for both. He is employed at Griffith University where he holds an NHMRC Australia Fellowship. His Awards include the Eureka Prize for Leadership and a Queensland Great Award. He was elected to Honorary Fellowship of the Royal Australasian College of Physicians, The Queensland Academy of Arts and Sciences and the Australian Academy of Technological Sciences and Engineering. He is a former Director of QIMR and a former Chairman of NHMRC Council.